Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.

ABSTRACT:

SUBMITTER: Ndiaye BP 

PROVIDER: S-EPMC4648060 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature